Cell Isolation Market - Growth Prospects for Global Players - Exclusive Report by MarketsandMarkets™


Posted October 8, 2021 by mmvaidya

This study involved four major activities in estimating the current size of the cell isolation market.
 
According to the new market research report, "Cell Isolation/Cell Separation Market by Product (Reagents, Beads, Centrifuge), Cell Type (Human, Animal), Cell Source (Bone Marrow, Adipose), Technique (Filtration), Application (Cancer, IVD), End-User (Hospitals, Biotechnology) - Global Forecast to 2025" The global Cell Isolation market size is projected to reach USD 15.0 billion by 2025 from USD 6.9 billion in 2020, at a 16.8% CAGR.

Browse and in-depth TOC on “Cell Isolation Market”
411 – Tables
38 – Figures
264 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=103931479

Growth Boosting Factors:

Growth in this market is largely driven by factors such as the increasing government funding for cell-based research, the increasing number of patients suffering from cancer and infectious diseases, technological advancements, and the growing focus on personalized medicine. On the other hand, ethical issues related to embryonic stem cell isolation and the high cost of cell-based research are expected to limit market growth to a certain extent in the coming years.

Global Key Players:

The major players in this market are Thermo Fisher Scientific, Inc. (US), Becton, Dickinson and Company Limited (US), Beckman Coulter Inc. (US).Merck KGaA (Germany), Terumo BCT (Japan), GE Healthcare (US), Bio- Rad Laboratories Inc. (US), Corning Inc. (US), Roche Diagnostics (Switzerland, Alfa Laval (Sweden), Miltenyl Biotech (Germany), pluriSelect Life Science (Germany), STEMCELL Technologies Inc. (Canada), Akadeum Life Sciences, Inc (US), Bio- Techne (US), Bio Legend (US) and Invent Biotechnologies (US).

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=103931479

Thermo Fisher Scientific accounted for the largest share of the cell isolation market in 2019. The company offers an exhaustive product portfolio comprising various cell isolation products, such as reagents and kits, media, magnetic beads, and centrifuges. The company pursues both organic as well as inorganic growth strategies to enhance its market position. To maintain its leading position and enhance its market share, the company is customer-oriented and maintains a strong relationship with its customers.

In 2019, Becton, Dickinson and Company accounted for the second-largest share of the cell isolation market. It operates in the cell isolation market through its BD Biosciences segment.The company has an extensive product portfolio, ranging from instruments to accessories. It also has a strong distribution network for flow cytometers, reagents, kits, and magnetic separators. The company has been focusing on technological advancements as its key growth strategy, to maintain its position in the market.

Beckman Coulter, Inc. was the third-largest player in the cell isolation market, in 2019. To sustain its leadership position in the market, the company focuses on continuous innovation and product development. For instance, the company launched its ClearLLab 10C System for the clinical flow cytometry lab in 2019. The new system includes the first 10-color CE-IVD panels of immunophenotyping reagents for both lymphoid and myeloid lineages. The tubes utilize DURA Innovations dry reagent technology for the panels, which requires no refrigeration. It also focuses on R&D investments to introduce new products into the market. With its strong portfolio of cell isolation products, the company is likely to maintain its leadership position in this market.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=103931479

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
Email: [email protected]
Content Source: https://www.marketsandmarkets.com/PressReleases/cell-isolation.asp
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/cell-isolation-market.asp
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Makarand Vaidya
Country United States
Categories Industry , Medical , News
Tags cell isolation , cell isolation market
Last Updated October 8, 2021